Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Repro Med Systems Inc. logo

Repro Med Systems Inc.

Sector: Manufacturing   

Industry: Surgical and Medical Instrument Manufacturing

2.11
 
USD
  
-0.04
  
(-1.86%)
Optionable: Yes  Market Cap: 98 M  90-day average vol: 76,901

Previous close: 2.15  Open: 2.15  Bid: 2.02  Ask: 2.5
52 week range    
1.98   
   4.48
Peers   
NUVA / 
NVCN-CA / 
NURO / 
Last updated: Wednesday 21st February 2024
45
MarketXLS Rank
40
Value
46
Technical
50
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NUMD

0 B-1.50.03

NURO

0 B-114.51

NUVA

3 B-10449.37

NVCN-CA

Financials

KRMD Income Statement

Annual
Feb-12Feb-13Feb-14Feb-16Feb-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles58722.059842.0
Basic EPS from continuing operations-0.03-0.1
Basic EPS total0.020.020.020.02-0.010.020.01-0.03-0.1-0.19
Basic weighted shares outstanding34 M36 M37 M38 M38 M38 M39 M42 M44 M45 M
Cost of sales-2 M-3 M-3 M-5 M-5 M-7 M-8 M9 M10 M-13 M
Depreciation103981.0190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0
Depreciation unreconciled103981.0190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0
DepreciationAndAmortization103981.0190971.0232959.0271566.0300611.0309263.0340229.0418595.0463130.0587137.0
Diluted EPS total0.020.020.020.02-0.010.020.01-0.03-0.1-0.19
Diluted normalized net income/share-0.03-0.1
Diluted weighted shares outstanding35 M36 M37 M38 M38 M39 M39 M42 M44 M45 M
GainOnSaleOfPPE4930.047830.016591.01009.0
GeneralAndAdministrativeExpense-132504.0-132504.0-132504.0-170956.012 M18 M-645784.0
Gross operating profit4 M5 M5 M8 M8 M11 M15 M15 M14 M15 M
Income before tax1 M1 M1 M1 M-776699.01 M696418.01 M-6 M-11 M
Income taxes465291.0312347.0307024.0359706.0-241700.0266380.0132069.0-17800.0-2 M-2 M
InterestExpenseNonOperating31540.028280.04547.03412.01886.0-239.0237.060.0-5393.0
MiscOtherSpecialCharges-9198.02937.028104.080663.042395.0692990.0145587.0
Net income from total operations815893.0725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M
NetIncomeCommonStockholders815893.0725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M
NetIncomeContinuousOperations815893.0725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M
NetNonOperatingInterestIncomeExpense-18692.0-20199.02879.0-3412.0-1886.0239.0-237.0-60.05393.0
NonRecurringOperationExpense899003.03 M2 M
Normalized income-8 M
Operating income1 M1 M1 M1 M-736251.02 M4 M-1 M-7 M-11 M
Operating income before depreciation (EBITDA)1 M1 M1 M1 M-446202.01 M1 M2 M-6 M-10 M
OperatingExpense3 M4 M-4 M-6 M-8 M-10 M-14 M16 M21 M-26 M
Other income net9198.0-2937.0-33034.0-128493.0-58986.0-693999.0-145587.0
OtherGandA-132504.0-132504.0-132504.0-170956.012 M18 M-645784.0
OtherOperatingExpenses-149594.0216913.0296080.0-514294.0
RentAndLandingFees-132504.0-132504.0-132504.0
Research & development expense90329.0147576.0218150.0207282.0237486.0241124.0740475.01 M2 M5 M
ResearchExpense90329.0147576.0218150.0207282.0237486.0241124.0740475.01 M2 M5 M
Revenue per share-80100.0-131850.0-4837.05302.02586.0-50895.0
SalariesAndWages-131850.03 M-3 M
Selling Gen & administrative expense3 M4 M4 M6 M8 M8 M10 M12 M18 M21 M
SellingAndMarketingExpense3 M4 M4 M6 M8 M8 M10 M21 M
SellingExpense3 M4 M4 M6 M8 M8 M10 M21 M
Special income/charges-899003.0-3 M-2 M
Total Income available for interest expense (EBIT)1 M1 M1 M1 M-774813.01 M696179.01 M-6 M-11 M
Total common shares outstanding35 M37 M37 M38 M38 M38 M40 M44 M45 M46 M
Total net income815893.0725763.0703429.0782864.0-534999.0910570.0564349.0-1 M-5 M-9 M
Total ordinary shares46 M46 M46 M46 M46 M46 M46 M46 M46 M46 M
Total revenues6 M8 M9 M12 M12 M17 M23 M24 M23 M28 M
TotalExpenses598580.01 M-8 M-11 M-13 M-16 M-23 M25 M31 M-39 M
TotalRevenue6 M8 M9 M12 M12 M17 M23 M24 M23 M28 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University